Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes

被引：0
|
作者：
Can Hu
Wen-jun Yin
Dai-yang Li
Jun-jie Ding
Ling-yun Zhou
Jiang-lin Wang
Rong-rong Ma
Kun Liu
Ge Zhou
Xiao-cong Zuo
机构：
[1] Central South University,Department of Pharmacy, The Third Xiangya Hospital
[2] Children’s Hospital of Fudan University,Department of Pharmacy
[3] First Affiliated Hospital of Xinjiang Medical University,Department of Pharmacy
[4] Central South University,Center of Clinical Pharmacology, The Third Xiangya Hospital
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Population pharmacokinetics; Tacrolimus; Evaluation; Renal transplant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1437 / 1447
页数：10
相关论文
共 50 条
  • [1] Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
    Hu, Can
    Yin, Wen-jun
    Li, Dai-yang
    Ding, Jun-jie
    Zhou, Ling-yun
    Wan, Jiang-lin
    Ma, Rong-rong
    Liu, Kun
    Zhou, Ge
    Zuo, Xiao-cong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (11) : 1437 - 1447
  • [2] Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant Recipients
    Campagne, Olivia
    Mager, Donald E.
    Brazeau, Daniel
    Venuto, Rocco C.
    Tornatore, Kathleen M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1184 - 1195
  • [3] TACROLIMUS POPULATION PHARMACOKINETICS AND CYP3A5 GENOTYPES IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
    Campagne, O.
    Mager, D. E.
    Brazeau, D.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S18 - S18
  • [4] Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
    Zuo, Xiao-cong
    Ng, Chee M.
    Barrett, Jeffrey S.
    Luo, Ai-jing
    Zhang, Bi-kui
    Deng, Chen-hui
    Xi, Lan-yan
    Cheng, Ke
    Ming, Ying-zi
    Yang, Guo-ping
    Pei, Qi
    Zhu, Li-jun
    Yuan, Hong
    Liao, Hai-qiang
    Ding, Jun-jie
    Wu, Di
    Zhou, Ya-nan
    Jing, Ning-ning
    Huang, Zhi-jun
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 251 - 261
  • [5] Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients
    Zhu, Wan
    Xue, Ling
    Peng, Hongwei
    Duan, Zhouping
    Zheng, Xuelian
    Cao, Duanwen
    Wen, Jinhua
    Wei, Xiaohua
    PHARMACOGENOMICS, 2018, 19 (13) : 1013 - 1025
  • [6] CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
    Chen, Lucy
    Prasad, G. V. Ramesh
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018, 11 : 23 - 33
  • [7] Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients
    Kotha, Chandini
    Sahay, Manisha
    TRANSPLANTATION, 2022, 106 (09) : S135 - S135
  • [8] Impact of CYP3A5 genotype on tacrolimus management in adult heart transplant recipients
    Pasternak, Amy
    Hong, Je-Won
    Lewis, Sarah
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 35 - 36
  • [9] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [10] Effect of drug combination on tacrolimus target dose in renal transplant patients with different CYP3A5 genotypes
    Zhang, Shu-Fang
    Tang, Bo-Hao
    Wei, An-Hua
    Du, Yue
    Guan, Zi-Wan
    Li, Yan
    XENOBIOTICA, 2022, 52 (03) : 312 - 321
12345